Related references
Note: Only part of the references are listed.Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis
Jiwen Cheng et al.
PLOS ONE (2014)
Cell surface protein glycosylation in cancer
Maja N. Christiansen et al.
PROTEOMICS (2014)
Altered tumor-cell glycosylation promotes metastasis
Irina Hauselmann et al.
FRONTIERS IN ONCOLOGY (2014)
Absolute Quantitation of Immunoglobulin G and Its Glycoforms Using Multiple Reaction Monitoring
Qiuting Hong et al.
ANALYTICAL CHEMISTRY (2013)
CA 19-9: handle with care
Claudio Galli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
n Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome
Georgios Androutsopoulos et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2013)
PNGase F catalyzes de-N-glycosylation in a domestic microwave
Hui Zhou et al.
ANALYTICAL BIOCHEMISTRY (2012)
Glycans as cancer biomarkers
Barbara Adamczyk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer
Jeong-Gu Kang et al.
BMB REPORTS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
Frederick R. Ueland et al.
OBSTETRICS AND GYNECOLOGY (2011)
CA 15-3: Uses and limitation as a biomarker for breast cancer
Michael J. Duffy et al.
CLINICA CHIMICA ACTA (2010)
α-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes
A. I. Potapovich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Utility of Lens culinaris Agglutinin-Reactive Fraction of alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin, Alone or in Combination, as Biomarkers for Hepatocellular Carcinoma
Richard K. Sterling et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Yong-Sam Kim et al.
PROTEIN AND PEPTIDE LETTERS (2009)
Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the Invasive/Metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1
Yong-Sam Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways
HB Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry
H Zhang et al.
NATURE BIOTECHNOLOGY (2003)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6 GlcNAc branching
S Ihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Improved method for pepsinolysis of mouse IgG1 molecules to F(ab′)2 fragments
DS Wilson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Hemopexin: a review of biological aspects and the role in laboratory medicine
JR Delanghe et al.
CLINICA CHIMICA ACTA (2001)
Share Paper
